David Yardeni, Julianna Gershbaum Tobin, Bryan Itkowitz, Inna Lipnizkiy, Ali Abu Juma'a, Naim Abu‐Freha, Ayelet Keren‐Naus, May Turgeman, Anat Nevo-Shor, Robert Gareth Gish, Ohad Etzion
BACKGROUNDDespite the existence of an effective vaccine and treatment for the hepatitis B virus (HBV) more than 880000 people die each year from complications of cirrhosis and hepatocellular carcinoma associated with chronic HBV (CHB) infection.Limited information exists regarding the effect of antiviral treatment or the effect of patient